Detalhe da pesquisa
1.
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia.
Blood
; 139(9): 1340-1358, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788382
2.
ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model.
Blood
; 134(5): 432-444, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31151986
3.
Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia.
Haematologica
; 106(6): 1608-1615, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414849
4.
Leukemic B Cell CTLA-4 Suppresses Costimulation of T Cells.
J Immunol
; 202(9): 2806-2816, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30910862
5.
CLEAR: coverage-based limiting-cell experiment analysis for RNA-seq.
J Transl Med
; 18(1): 63, 2020 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32039730
6.
Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia.
Blood
; 131(26): 2943-2954, 2018 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29695515
7.
Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia.
Cytotherapy
; 22(7): 369-376, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32303428
8.
Chronic Lymphocytic Leukemia-Derived IL-10 Suppresses Antitumor Immunity.
J Immunol
; 200(12): 4180-4189, 2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29712773
9.
Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts.
Blood
; 127(23): 2879-89, 2016 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27013443
10.
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia.
Blood
; 127(9): 1117-27, 2016 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26813675
11.
The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34+CD123+ cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donors.
Haematologica
; 103(8): 1288-1297, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29773600
12.
Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 22(4): 658-668, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26743340
13.
Magnetic tweezers-based 3D microchannel electroporation for high-throughput gene transfection in living cells.
Small
; 11(15): 1818-1828, 2015 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25469659
14.
Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing.
Blood
; 122(19): 3308-16, 2013 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24009233
15.
Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia.
Blood
; 121(1): 136-47, 2013 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23165478
16.
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.
Blood
; 122(15): 2539-49, 2013 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23886836
17.
CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous Leukemia.
Mol Pharm
; 12(6): 2010-8, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25871632
18.
Externally validated predictive clinical model for untreated del(17p13.1) chronic lymphocytic leukemia patients.
Am J Hematol
; 90(11): 967-9, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26202978
19.
Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties.
J Immunol
; 190(6): 2702-11, 2013 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23418626
20.
Fcγ receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies.
J Biol Chem
; 288(37): 26800-9, 2013 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23902770